We’re thrilled to have our linked comment published in @thelancet.com
The future of cancer control depends on decisive, collective action today.
🔗 Read it here: doi.org/10.1016/S014...
📄 Original article: doi.org/10.1016/S014...
@daffodilcentre.org
@sydney.edu.au

NEW RESEARCH🔬| We are excited to share the first long-term projections for cancer prevalence linked to key pan-tumour biomarkers in Australia.

🔍This study aims to inform health policy and healthcare planning for targeted therapies.

🌐Read the full article🔗 doi.org/10.1016/j.la...

Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042 We present the first long-term projections for cancer prevalence associated with key pan-tumour biomarkers in Australia, to inform health policy and healthcare planning for targeted therapies.

🆕 First long-term #projections for #cancer prevalence associated with key #PanTumour #biomarkers in #Australia to 2042, to inform health policy & planning for targeted therapies.

#MedSky #OncSky @daffodilcentre.bsky.social
@juliasteinberg.bsky.social @qingweiluo.bsky.social

🔗Check out full text!

NEW RESEARCH🔬| This pilot, randomised waitlist-controlled trial aimed to evaluate the feasibility, acceptability, and safety of #iConquerFear, a self-guided online fear of cancer recurrence intervention for #OvarianCancer survivors.

🌐Read the full article🔗 doi.org/10.1186/s128...